• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

NESTE Q3’24: No quick fixes

NESTE08.11.2024, 15.43
Sara Antonacci, Petri Gostowski
Discuss

Neste: a new CEO is in place, but the short-term turmoil continues. The key uncertainty factors are the gross margin in Renewable Products and the current oversupply in the market. Valuation of the share is mixed and multiples very high with this year's weak performance - still long term potential. Analyst Petri Gostowski summarizes.

Content:
00:00 Intro
00:21 Q3
01:11 How can Neste improve the situation?
02:21 Oversupply in the market
02:59 Other key factors 
04:07 Valuation
05:54 Recommendation

Stay up to date
Analyst Interviews

Upcoming webcasts

Recent videos

HCA Morgenbørs 04/08 - Positiv åbning på forventninger om en nedtrapning af konflikten i Iran
04.08.2026, 09.16 Novo Nordisk
Asmodee, Audiocast, Q1'26
04.08.2026, 09.00 Asmodee
Aspo Oyj, Webcast, Q2'26
03.08.2026, 11.00 Aspo
HCA Morgenbørs 03/08 - Prisfald i olie driver positivt marked
03.08.2026, 09.28 Novo Nordisk
Outokumpu, Webcast, Q2'26
30.07.2026, 13.30 Outokumpu
View all videos